Pure Biologics (WAR:PUR) Other Stockholders Equity : zł96.36 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Other Stockholders Equity?

Pure Biologics's Other Stockholders Equity for the quarter that ended in Sep. 2024 was zł96.36 Mil.

Pure Biologics's quarterly Other Stockholders Equity stayed the same from Mar. 2024 (zł94.49 Mil) to Jun. 2024 (zł94.49 Mil) but then increased from Jun. 2024 (zł94.49 Mil) to Sep. 2024 (zł96.36 Mil).

Pure Biologics's annual Other Stockholders Equity increased from Dec. 2021 (zł70.89 Mil) to Dec. 2022 (zł75.31 Mil) and increased from Dec. 2022 (zł75.31 Mil) to Dec. 2023 (zł94.49 Mil).

Pure Biologics Other Stockholders Equity Historical Data

The historical data trend for Pure Biologics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics Other Stockholders Equity Chart

Pure Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

13.07

16.82

70.89

75.31

94.49

Pure Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															94.49	94.49	94.49	94.49	96.36

Pure Biologics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Pure Biologics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pure Biologics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pure Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.purebiologics.pl

Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics Headlines

No Headlines